Metastatic Burden in Hormone-Naive Prostate Cancer: A Tale of Two Subgroups

被引：1
|
作者：
Haran, A. M. [1 ,2 ,3 ,4 ]
Ali, A. [1 ,2 ,3 ]
Clarke, N. W. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Manchester, Div Canc Sci, Genitourinary Canc Res Grp, Manchester, Lancs, England
[2] Univ Manchester, Div Canc Sci, FASTMAN Ctr Excellence, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Dept Surg, Wilmslow Rd, Manchester M20 4BX, Lancs, England
[4] Salford Royal NHS Fdn Trust, Dept Urol, Manchester, Lancs, England
来源：
CLINICAL ONCOLOGY | 2020年 / 32卷 / 03期
关键词：
D O I：
10.1016/j.clon.2019.12.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：209 / 212
页数：4
相关论文
共 50 条
  • [21] Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
    S Merson
    Z H Yang
    D Brewer
    D Olmos
    A Eichholz
    F McCarthy
    G Fisher
    G Kovacs
    D M Berney
    C S Foster
    H Møller
    P Scardino
    J Cuzick
    C S Cooper
    J P Clark
    British Journal of Cancer, 2014, 110 : 1655 - 1662
  • [22] Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
    Merson, S.
    Yang, Z. H.
    Brewer, D.
    Olmos, D.
    Eichholz, A.
    McCarthy, F.
    Fisher, G.
    Kovacs, G.
    Berney, D. M.
    Foster, C. S.
    Moller, H.
    Scardino, P.
    Cuzick, J.
    Cooper, C. S.
    Clark, J. P.
    BRITISH JOURNAL OF CANCER, 2014, 110 (06) : 1655 - 1662
  • [23] Genomic profiling of hormone-naive lymph node metastases in patients with prostate cancer
    Paris, Pamela L.
    Hofer, Matthias D.
    Albo, Giancarlo
    Kuefer, Rainer
    Gschwend, Juergen E.
    Hautmann, Richard E.
    Fridyland, Jane
    Simko, Jeffrey
    Carroll, Peter R.
    Rubin, Mark A.
    Collins, Colin
    NEOPLASIA, 2006, 8 (12): : 1083 - U54
  • [24] Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC)
    Smith, Matthew Raymond
    Borre, Michael
    Rathenborg, Per
    Werbrouck, Patrick
    Van Poppel, Hendrik
    Heidenreich, Axel
    Iversen, Peter
    Baskin-Bey, Edwina
    Perabo, Frank
    De Phung
    Tombal, Bertrand
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] PREVALENCE OF METABOLIC SYNDROME AND ITS COMPONENTS IN MEN WITH HORMONE-NAIVE PROSTATE CANCER
    Di Francesco, Simona
    Nicolai, Michele
    Como, Antonio
    Altieri, Vincenzo
    Castellan, Pietro
    Campanelli, Manuel
    Tenaglia, Raffaele Lanfranco
    ANTICANCER RESEARCH, 2010, 30 (04) : 1509 - 1510
  • [26] Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
    Lilleby, Wolfgang
    Gaudernack, Gustav
    Brunsvig, Paal F.
    Vlatkovic, Ljiljana
    Schulz, Melanie
    Mills, Kate
    Hole, Knut Hakon
    Inderberg, Else Marit
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (07) : 891 - 901
  • [27] Impact of nutritional status on the prognosis of patients with metastatic hormone-naive prostate cancer: a multicenter retrospective cohort study in Japan
    Okamoto, Teppei
    Hatakeyama, Shingo
    Narita, Shintaro
    Takahashi, Masahiro
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishida, Masanori
    Kawaguchi, Toshiaki
    Ishidoya, Shigeto
    Shimoda, Jiro
    Sato, Hiromi
    Mitsuzuka, Koji
    Tochigi, Tatsuo
    Tsuchiya, Norihiko
    Arai, Yoichi
    Habuchi, Tomonori
    Ohyama, Chikara
    WORLD JOURNAL OF UROLOGY, 2019, 37 (09) : 1827 - 1835
  • [28] DocetaxelLiver toxicity following an off-label use of docetaxel for metastatic hormone-naive prostate cancer: case report
    Reactions Weekly, 2018, 1716 (1) : 122 - 122
  • [29] Zoledronic Acid Improves Clinical Outcomes in Patients with Bone Metastatic Hormone-naive Prostate Cancer in a Multicenter Clinical Trial
    Okegawa, Takatsugu
    Higaki, Masao
    Matsumoto, Tetsuo
    Kase, Hiroshi
    Murata, Akihiro
    Noda, Kenjiro
    Noda, Haruhisa
    Asaoka, Hiroshi
    Oshi, Masaya
    Tomoishi, Junzo
    Uchida, Hiroji
    Higashihara, Eiji
    Nutahara, Kikuo
    ANTICANCER RESEARCH, 2014, 34 (08) : 4415 - 4420
  • [30] Retrospective validation of bone risk stratification criteria for men with de novo metastatic hormone-naive prostate cancer in China
    Zhang, Yang
    Ding, Li
    Zheng, Yuxin
    Wang, Kun
    Xia, Wentao
    Wang, Junqi
    Ge, Peng
    PEERJ, 2023, 11
12345